UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: (Date of earliest event reported): November 14, 2000
Huntingdon Life Sciences Group plc ("Huntingdon")
---------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
England
---------------------------------------------------------------------
(State or other jurisdiction of incorporation)
1-10173 N/A
------------------------------- --------------------------------
(Commission File Number) (I.R.S. Employer Identification Number)
Huntingdon Research Centre, Woolley Road, Alconbury, Huntingdon,
Cambs, PE 17 5HS, England
---------------------------------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, including area code: +44 (1480) 892000
-----------------
---------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 7 EXHIBITS
(c) Exhibits
Exhibit No. Description
99.1 Press release issued by Huntingdon Life Sciences Group plc
on November 14, 2000 announcing its earnings in respect of the
quarter ended September 30, 2000.
Item 9 REGULATION FD DISCLOSURE
On November 14, 2000, Huntingdon Life Sciences Group plc (the "Company") issued
a press release, attached as Exhibit No. 99.1 hereto, announcing its earnings in
respect of the quarter ended September 30, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
HUNTINGDON LIFE SCIENCES GROUP PLC
/s/ Julian Griffiths
By: Julian Griffiths
GROUP COMPANY SECRETARY
Dated: November 14, 2000
<PAGE>
EXHIBIT INDEX
Exhibit No. Description
99.1 Press release issued by Huntingdon Life Sciences Group plc
on November 14, 2000 announcing its earnings in respect of the
quarter ended September 30, 2000.
<PAGE>
Exhibit 99.1
